Senior Director, Head of Protein Technologies
Nathan has been innovating in the field of antibody discovery and engineering for 15 years in both academia and industry. Beginning his career in antibody technology at Imperial College London in 2004 on a prestigious Wellcome Trust grant, Nathan’s Ph.D focused on developing a phage display based method for engineering bi-paratopic antibodies. In 2008, he further advanced these efforts at Pfizer, Ltd in Sandwich, UK, and later at Pfizer, Inc. in Cambridge, MA, where Nathan co-invented a proprietary bispecific antibody platform and lead numerous cross-functional technology teams on large molecule projects across multiple disease areas including inflammation, autoimmunity, and oncology at stages spanning from project initiation through to drug candidate nomination, and IND filing.
In an exciting and challenging departure from traditional industry, Nathan also joined Google [x] (later, Google Life Sciences) in Mountain View, CA, to support the development and launch of Verily Life Sciences, where he played a key role in the development of protein-based capabilities designed to support a diagnostic nanoparticle platform. Later, returning to Pfizer, Nathan took on a leadership role within the BioMedicine Design organization where he led a phage display team supporting therapeutic antibody discovery and optimization projects at Pfizer’s Centers for Therapeutic Innovation, Boston.
With a strong belief that organizations can only truly succeed when people feel safe in bringing all of who they are to work, Nathan co-founded the MA chapter of a Pfizer Colleague Resource Group for LGBT employees and allies – a group that provided both a social and networking forum for employees, and successful partnerships with Boston Pride, the Human Rights Campaign, and Gay & Lesbian Advocates & Defenders. As part of the Pandion Therapeutics leadership team, Nathan intends to apply this experience, and commitment to Diversity & Inclusion, across all facets of employment and culture of the organization.